Stage FocusSeed, Series A
GeographyUS, Global
TypeVC
Last Activity2025
Industry Focus
Industries
Biotech
Technical BenchStrong
Investor TypeDeepTech Specialist
ExposureMostly DeepTech Investments
Bio
Frazier Life Sciences is a Palo Alto-based firm that has raised $3.6B+ across 5 venture funds since 2016. Fund XII, at $1.3B (2025), is the largest to date and targets company creation and early-stage biopharmaceutical investment. Portfolio companies have produced 40+ FDA-approved therapeutics since 2010.
Notable exits include Chinook Therapeutics ($3.5B acquisition by Novartis) and Alpine Immune...
Notable Investments
C
Chinook TherapeuticsA
Alpine Immune SciencesM
Maze TherapeuticsSimilar Funds
Catalio Capital Management
New York, United States
DeepTech NativeBiotechMedTechSeedSeries A
Deerfield Management
New York, United States
DeepTech NativeBiotechMedTechSeedSeries A
Leaps by Bayer
Leverkusen, Germany
DeepTech NativeBiotechAgriTechMedTechSeedSeries A
LongeVC
Washington DC, United States
DeepTech NativeBiotechSeedSeries A
4BIO Capital
Geneva, Switzerland
DeepTech NativeBiotechSeedSeries A
Abingworth
London, United Kingdom
DeepTech NativeBiotechMedTechSeedSeries A